Evolva Holding SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evolva Holding SA with three other
miscellaneous service companies in Europe:
Veloxis Pharmaceuticals A/S
sales of 62.00 million Danish Kroner [US$9.33 million]
of which 100%
was Pharmaceutical Preparations),
(9.08 million Euro [US$10.16 million]
based in France
(8.87 million Euro [US$9.93 million]
Evolva Holding SA reported sales of 9.58 million Swiss Francs (US$9.87 million)
December of 2016.
decrease of 28.3%
versus 2015, when the company's sales were 13.36 million Swiss Francs.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Evolva Holding SA had sales
of 10.54 million Swiss Francs.